Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.215 USD | +7.67% | +3.08% | -18.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.54% | 1.04B | |
+1.81% | 42.59B | |
+8.41% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.91% | 24.81B | |
-24.34% | 18.17B | |
+28.65% | 12.05B | |
-3.03% | 11.7B | |
+7.14% | 11.1B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : Goldman Sachs Downgrades Vir Biotechnology to Neutral Rating From Buy, Adjusts Price Target to $62 From $64